Home›Search›European Health and Pharmaceutical Law Review

European Health and Pharmaceutical Law Review

Lexxion Verlagsgesellschaft mbH · Germany · Est. 2022

ISSN2751-3971

SJR Q4✓ Scopus / SJR

/ 100

High Risk

Score Breakdown

✓ Scopus Q4+5

Total5

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals.

SJR Score

0.106

H-Index

Total Works

Total Citations

2yr Mean Citedness

0.02

Free JIF alternative

Aims & Scope✦ Compiled from public sources

The European Health & Pharmaceutical Law Review addresses pharmaceutical law and policy issues, legal and regulatory developments on the national, EU, and international levels. It covers medicines law, issues related to the European Medicines Agency (EMA), medical devices, artificial intelligence, digital health, and big data.

AI-compiled from public web sources · verify on the publisher page

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

SJR Rank

Bottom 25%

General Information

Country / RegionGermany

Primary Language—

1st Year Published2022

Annual Volume~ 17 articles / year

StatusActive (last: 2025)

Total Publications74

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

4/12 · 33%

✅

Do you know the journal / publisher?

Lexxion Verlagsgesellschaft mbH

❌

Does the journal have a website?

No URL

✅

Is the ISSN verified?

2751-3971

✅

Indexed in a trusted database?

Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

❌

Primary language documented?

N/A

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Times cited

2022

2023

2024

2025

2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Drug DiscoveryQ4

LawQ4

Pharmaceutical ScienceQ4

Pharmacology, Toxicology and Pharmaceutics (miscellaneous)Q4

Subject Classification

Scopus Categories

Pharmacology, Toxicology and Pharmaceutics (miscellaneous)LawDrug DiscoveryPharmaceutical Science

Research Topics (OpenAlex)

Health Systems, Economic Evaluations, Quality of LifePharmaceutical Economics and PolicyIntellectual Property and PatentsBiomedical Ethics and RegulationEthics in Clinical ResearchLaw, AI, and Intellectual PropertyCOVID-19 Digital Contact TracingHealthcare Policy and ManagementScience, Research, and MedicineEU Law and Policy Analysis